The global dental implants and biomaterials market, valued at $3 billion in 2009, is expected to grow at a compound annual growth rate (CAGR) of 13% and exceed $7 billion by 2016, according to a new report from GlobalData.
The market is expected to be driven by various initiatives taken by the leading market players to increase the visibility of the brands in addition to increasing the awareness among the patient population, the company announced.
Companies such as Nobel Biocare and Biomet 3i are actively engaged in programs aimed at symbiotic development to expand the scope and size of the business, GlobalData noted. These include development of complementary supporting technologies such as software and visualization systems, training and development programs for key opinion leaders, and industry partnership programs for overall development.
With a 30% share of the total global revenues, the U.S. is the largest market for dental implants and biomaterials, and the market is expected to grow at 14% CAGR between 2009 and 2016, according to GlobalData. It is forecast to remain the largest revenue contributor for the dental implant and biomaterials market in 2016, accounting for nearly 32% of the global revenues.
Copyright © 2011 DrBicuspid.com
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
